Journal  /  Bakuchiol

Bakuchiol: Does the "Natural Retinol" Actually Work?

Search "retinol alternative" in 2026, and one word dominates the results: bakuchiol. Google Trends shows searches up 49% year-over-year. Every third clean-beauty brand has launched a bakuchiol serum. Sephora, Cult Beauty, dermatologists on TikTok — everyone talks about it. The consumer story is simple: retinol works but irritates; bakuchiol works and is gentle; therefore bakuchiol is better.

That story has real evidence behind it. It also has three complications the marketing conveniently skips.

We spent the last two weeks reading every peer-reviewed paper we could find on bakuchiol, tracking the ingredient supplier's own commercial materials, and pulling independent lab analyses of what's actually inside the products on your shelf. Here's what we found.

---

Line 1: Where the "natural retinol" idea actually came from

Bakuchiol is a molecule — a meroterpene phenol, formula C₂₂H₃₄O₂ — first isolated in 1966 from the seeds of Psoralea corylifolia, a plant native to India and China. It has been used in Ayurvedic and Traditional Chinese Medicine for centuries. That's the botanical origin story. It is not, by itself, evidence of anything.

The "natural retinol" framing dates to a specific paper: Chaudhuri & Bojanowski, 2014, published in the International Journal of Cosmetic Science, titled "Bakuchiol: a retinol-like functional compound revealed by gene expression profiling and clinically proven to have anti-aging effects." The paper used gene expression profiling in reconstructed human skin models and showed that bakuchiol activates a set of genes that overlaps substantially with retinol's — collagen types I, III, IV; aquaporin 3; matrix metalloproteinase modulation. Different molecular pathway (MAPK/ERK rather than the retinoic acid receptor), same downstream effect on skin biology.

This is real science. It's also worth being clear about: the authors, Ratan Chaudhuri and Krzysztof Bojanowski, work for Sytheon Ltd, the New Jersey ingredient supplier that manufactures the branded bakuchiol material (Sytenol® A) sold to cosmetic brands. This is disclosed in the paper. It doesn't make the work wrong. But it does mean the foundational scientific story of bakuchiol was written by the company that profits from selling bakuchiol.

Independent evidence came later — and there's less of it than the marketing suggests.

The single most important independent study is Dhaliwal et al., 2019, published in the British Journal of Dermatology. Prospective, randomised, double-blind, 12 weeks, 44 participants across four US universities. One group applied 0.5% bakuchiol cream twice daily; the other applied 0.5% retinol cream once daily. A board-certified dermatologist graded photographs blinded to which group each patient was in.

The findings were clean:

• Both compounds significantly decreased wrinkle surface area — no statistical difference between them.
• Both compounds significantly decreased hyperpigmentation — no statistical difference between them.
• The retinol group reported significantly more facial scaling and stinging.

That result — "as effective, less irritating" — is the entire consumer case for bakuchiol. It rests on a single, small, well-conducted trial. That's more than most cosmetic ingredients have. It's less than what phrases like "clinically proven alternative to retinol" imply.

A 2024 comprehensive review in the Journal of Integrative Dermatology pulled together seven studies from 2014 to 2021 (Chaudhuri 2014, Dhaliwal 2019, plus five smaller trials) and concluded bakuchiol "demonstrates clinically significant similarity to topical retinol in efficacy and superiority in tolerability and safety." The word we notice in that sentence is "similarity" — not "equivalence," not "superiority in efficacy." The reviewers were careful with their language. Marketing often isn't.

Line 2: What bakuchiol actually does, and why the "gene expression" argument matters

Retinol works because your skin converts it (in two enzymatic steps) into retinoic acid, which binds nuclear retinoic acid receptors (RAR/RXR) and switches on a set of genes that build collagen and regulate keratinocyte turnover. That mechanism is very well characterised. It's also the reason retinol irritates — the receptor activation is real and often intense.

Bakuchiol works through a completely different route. It has no structural resemblance to vitamin A, doesn't bind retinoic acid receptors, and doesn't require enzymatic conversion. It activates MAPK/ERK signalling and other pathways, which then turn on many of the same downstream genes — collagen types I, III, and IV; aquaporin 3; and, notably, it inhibits matrix metalloproteinase-12 more strongly than retinol itself does (MMP-12 is one of the enzymes that breaks down elastin, so this matters for skin firmness over time).

This is why the sensible way to describe bakuchiol is as a functional analogue rather than a "natural retinol." It gets to a similar destination through different chemistry. That difference is where its practical advantages come from:

• No retinization period. With retinol, the first 2-6 weeks are typically uncomfortable — dryness, peeling, redness while your skin adapts. Bakuchiol doesn't require your skin to adapt to receptor activation, so most people don't experience this phase.
• Daytime use. Retinol is photo-unstable and photosensitising, which is why it's a nighttime product. Bakuchiol is photo-stable and doesn't increase sun sensitivity — it can be used morning and evening.
• Layers well. Retinol has real compatibility problems (don't combine with acids, benzoyl peroxide, or vitamin C in the same routine). Bakuchiol is chemically neutral enough to work with almost anything, including — as an interesting twist — with retinol itself: some formulators use bakuchiol to stabilise retinol in combination products.

There is also a growing separate line of evidence for antioxidant activity. In cell-culture work, bakuchiol is roughly sixty times more effective than natural tocopherol (vitamin E) at protecting squalene from photo-oxidation, and it reduces UVB-induced inflammatory cytokines (IL-6, TNF-α) by 35-45% in keratinocyte cultures. That's laboratory data, not visible clinical endpoints, but it's mechanistically consistent with what you'd want from a daytime antioxidant.

Line 3: The industry scandal (most brands won't talk about this)

Here is where the story gets uncomfortable.

To carry the INCI name "Bakuchiol" on a cosmetic label in the EU, an ingredient must be at least 80% pure bakuchiol — meaning purified from other plant compounds. Sytheon's commercial-grade Sytenol® A is >99% pure. This purity requirement exists for a specific reason: the parent plant, Psoralea corylifolia, contains other phytochemicals that are actively harmful to skin — most notably psoralen and isopsoralen, molecules known as furocoumarins.

Furocoumarins are photo-sensitising. On sun exposure, they can cause serious skin reactions: erythema, dark pigmentation, blistering, phototoxic burns. They are so reactive that the International Fragrance Association (IFRA) sets a maximum permitted level for furocoumarins in cosmetic products of 1 part per million.

In 2024, Sytheon ran high-performance liquid chromatography analyses on 48 commercial products that claimed to contain "bakuchiol." A separate analysis, published on the same materials, looked at four "bakuchiol" products purchased on Amazon. The results were striking:

• Bakuchiol content ranged from 1.6% to 12.1% of the purified reference standard — meaning products marketed as "bakuchiol serums" contained a fraction, sometimes nearly none, of the active molecule the label implied.
• Psoralen and isopsoralen levels ranged from 1,000 to 5,000 ppm — one thousand to five thousand times higher than the IFRA safety ceiling.

The mechanism of this failure is not fraud in most cases — it is confusion at the ingredient level. Brands (or their manufacturers) buy "babchi oil" or "Psoralea corylifolia seed extract" believing it is bakuchiol. It is not. Those are raw plant extracts. They contain some bakuchiol, along with a variable and often dangerous mix of everything else in the seed. Labelling those extracts as "bakuchiol" is technically improper in the EU (they should be labelled by the botanical INCI name — Psoralea Corylifolia Seed Extract or Bakuchi Seed Oil), and functionally it's misleading — you're not getting the ingredient you think you are, and you might be getting the ingredient you specifically don't want.

A 2023 peer-reviewed paper in the Journal of Cosmetic Dermatology ("Finding the right Bakuchiol: Choose wisely") reviewed this exact problem and reached the same conclusion independently: consumers cannot tell purified bakuchiol from unpurified extract by looking at the marketing, and the difference between them is not "similar effect at slightly lower potency." It is "one is an actively researched skincare active; the other is a phototoxic raw material with an inconsistent bakuchiol content."

This is the part of the bakuchiol story that clean-beauty marketing systematically omits. The molecule works. The molecule when properly purified is safer than retinol. But a significant fraction of what's sold as bakuchiol is not the molecule at all.

---

The honest picture

Bakuchiol is worth taking seriously. It has a real mechanism, comparable-to-retinol clinical evidence in the specific parameters that were studied, a genuinely better tolerability profile, and unusual layering flexibility. For anyone who cannot tolerate retinol — sensitive skin, rosacea-adjacent skin, active eczema, or a personal preference for a plant-derived active — it is one of the strongest options available.

It is not, and never has been, "as strong as retinol" in a general sense. The evidence base is one small independent clinical trial, several company-authored mechanistic studies, and a handful of smaller supporting trials. That is more than most "hot ingredients" have; it is less than what the phrases "clinically proven" and "as effective as retinol" typically imply in industry copy.

Where it sits in the honest hierarchy of anti-aging actives, based on the peer-reviewed evidence to date:

• Grade A: prescription retinoids (tretinoin, isotretinoin) — largest effect sizes, largest evidence base, medical territory
• Grade A: retinol — well-studied non-prescription option, now restricted in the EU to 0.3% under Regulation 2024/996 (compliance dated November 2025)
• Grade B: bakuchiol — genuine mechanism, one strong independent RCT, replication limited, better tolerability

That's a defensible position — good enough that we've built a full evidence-graded reference entry for it in our compound registry. It's not the magic-natural-alternative version some brands are selling.

Practical use — where bakuchiol makes sense

Good fit:

• Sensitive, reactive, or rosacea-adjacent skin that has tried retinol and given up because of the irritation
• Anyone who wants a daytime anti-aging active (retinol is photo-unstable; bakuchiol is not)
• People building routines with multiple actives who want to avoid compatibility conflicts (bakuchiol layers well with almost everything)
• Perimenopausal skin, which often becomes drier and more reactive and tolerates retinoids poorly
• People who prefer plant-derived actives and want the actual purified molecule, not a wellness-market extract

Less compelling fit:

• People with photodamaged skin and high tolerance who want the largest possible effect — retinol (or, in the medical setting, prescription tretinoin) will do more, faster
• People who already tolerate retinol comfortably — there is no real reason to switch
• Anyone attracted purely by the "natural" framing and not by the specific benefits — that's a marketing preference, not a skin need

Pregnancy and breastfeeding. This is a specific question and we want to be careful. Bakuchiol is chemically unrelated to vitamin A and does not carry the same theoretical teratogenic concerns that led to the standard clinical recommendation to avoid retinoids in pregnancy. Multiple dermatologist-authored reviews describe it as a reasonable option to consider during pregnancy for that reason. However, dedicated pregnancy safety studies for bakuchiol do not exist. "No known risk" is not the same as "proven safe." If you are pregnant, trying to conceive, or breastfeeding, this is a conversation for your own doctor — not for a blog post, ours included.

Checking what you're buying

Given the industry-wide quality problem, a few things are worth checking on any bakuchiol product before you buy it:

• INCI name. The ingredient list should say "Bakuchiol" — not "Psoralea corylifolia seed oil," "Psoralea corylifolia seed extract," "babchi oil," or "bakuchi extract." Those latter names are legally distinct ingredients with meaningfully different safety profiles.
• Purity declaration or supplier reference. Brands using properly purified bakuchiol are usually willing to say so — either explicitly ("99% pure bakuchiol") or by referencing the supplier (Sytenol® A is the dominant cosmetic-grade material). If a brand won't tell you where their bakuchiol comes from, that's information.
• Concentration. Studied effective concentrations are 0.5% to 1%. Products at 0.1% or below are unlikely to deliver the clinical effects the marketing implies. Very high concentrations (above 2%) are unusual and don't clearly improve results.
• Packaging. Airless pumps or opaque bottles are preferable — bakuchiol itself is more stable than retinol, but formulations containing bakuchiol usually also contain other actives (vitamin C, peptides, antioxidants) that benefit from air- and light-protection.

Where this leaves us

Bakuchiol is the rare case where the science is honest, the mechanism is interesting, the tolerability advantage over retinol is real — and where the marketing has managed to run several miles ahead of what the peer-reviewed evidence actually says, while a significant chunk of the products on shelves don't contain what they claim.

The right response, we think, is not to reject the ingredient because the marketing is loud. It's to know what you're paying for, understand where it fits, and set expectations appropriately. Grade B is a good grade. It just doesn't mean "as good as prescription tretinoin" and it doesn't cover you against buying the wrong thing.

For our own registry, bakuchiol sits at Grade B — honest evidence, honest limits, honest use case. You can read the full compound entry with all cited sources here.

---

In the Registry

Full evidence-graded entries for the compounds discussed in this article:

• Bakuchiol — Grade B, meroterpene phenol from Psoralea corylifolia
• Retinol — Grade A, vitamin A alcohol; EU restricted to 0.3% (leave-on face) under Regulation 2024/996 from November 2025
• Niacinamide — Grade A, layers well with bakuchiol
• Hyaluronic Acid — Grade A, layers well with bakuchiol

---

Frequently asked questions

What is bakuchiol? A plant-derived molecule (a meroterpene phenol) isolated from the seeds of Psoralea corylifolia, a plant used in Ayurvedic and Traditional Chinese Medicine. It has no chemical relationship to vitamin A or the retinoids, despite being marketed as a "natural retinol."

Is bakuchiol as effective as retinol? A single 12-week randomised trial (Dhaliwal 2019) showed 0.5% bakuchiol was comparable to 0.5% retinol for reducing wrinkle surface area and hyperpigmentation, with less irritation. That's one small study, well-conducted but not yet independently replicated at larger scale. It supports "comparable in the specific parameters studied" — not "as effective in general."

Is bakuchiol safe during pregnancy? Bakuchiol is not chemically related to vitamin A and doesn't carry the theoretical teratogenic risks that make retinoids a standard "avoid during pregnancy" recommendation. Multiple dermatologist reviews describe it as a reasonable option to consider. However, dedicated pregnancy safety studies don't exist — "no known risk" is not the same as "proven safe." Consult your own doctor for individual advice.

Can I use bakuchiol with vitamin C? Yes. Unlike retinol, bakuchiol is chemically compatible with almost all other actives, including vitamin C (both L-ascorbic acid and its derivatives). Some routines use bakuchiol in the morning alongside vitamin C for combined antioxidant coverage, and any other active at night.

Can I use bakuchiol with copper peptides? Yes. Bakuchiol is compatible with copper peptides (GHK-Cu) — no known incompatibility. This is different from vitamin C, which destabilises copper peptides at the low pH vitamin C requires.

Why does the "Bakuchiol" label matter? To carry the INCI name "Bakuchiol" in the EU, the ingredient must be at least 80% pure. Unpurified extracts of Psoralea corylifolia contain psoralen and isopsoralen — phototoxic furocoumarins that can cause serious skin reactions. Independent lab analyses have found some products marketed as "bakuchiol" contain a fraction of the active molecule and up to 5,000× the safe limit of these phototoxic contaminants. Check the ingredient list for "Bakuchiol" specifically — not "babchi oil" or "Psoralea corylifolia seed extract."

What's the best concentration? Studied effective concentrations are 0.5% to 1%. Below 0.1%, the marketing outruns the evidence. Above 2%, there's no clear evidence of added benefit.

---

This article is part of our Journal — a plain-English series on skincare actives, grounded in the peer-reviewed evidence. Full source list and evidence-grades in the linked compound registry entries. We don't sell bakuchiol serums today. We hope this article helped you make a better decision about the ones you're considering.

Full evidence breakdown: GHK-Cu reference entry · how we grade.